You are here
AstraZeneca slumps on report CEO is heading to Teva
SHARES in AstraZeneca fell more than 5 per cent on Thursday after the company declined to deny a media report that chief executive Pascal Soriot was about to defect to Israel-based Teva Pharmaceutical Industries.
Mr Soriot, who has led the Anglo- Swedish company since 2012,
- CALL +65 6388 3838
- EMAIL email@example.com